fbpx

< Back to Thought Leadership

Blue & Co., LLC Announces New Director-in-Charge of Columbus, OH Office

COLUMBUS, Ohio (November 8, 2017) – Blue & Co., LLC is proud to announce that Larry King has been appointed to succeed Steve Sheridan as the Columbus, OH Office Director-in-Charge, effective January 1, 2018.

Larry King graduated with distinction from the Indiana University School of Business and began his career at Blue & Co. in September 1994 as a staff accountant in the Audit Department of the Carmel office. He transitioned to the firm’s Indianapolis office and the Healthcare practice in 1999, before moving to the Columbus, Ohio office in 2004. Larry’s professional development progressed steadily and resulted in his promotion to Director on January 1, 2013. He currently leads the audit and attestation services in the Columbus, Ohio office and he has served on multiple internal committees.

Steve Sheridan has lead the Columbus, Ohio office since 2015 and has influenced significant office growth in that time. He was also a driving force in the firm’s recognition as a Best Places to Work in Ohio award recipient, having secured the number one slot for large companies. Steve will be retiring as of December 31, 2018 and will assist in transitioning the responsibilities of Director-in-Charge to Larry throughout the coming year.

About Blue and Co.

Blue & Co., LLC is an independent accounting and advisory firm with more than 450 people in 13 offices across Indiana, Ohio, Kentucky and Texas. With over 45 years of experience, Blue & Co.’s public accounting expertise includes the practice areas of assurance, tax compliance and consulting, healthcare consulting, benefit plan services, valuation and litigation support, and business services. Its industry specializations include manufacturing & distribution, healthcare, construction, nonprofit, technology, financial services organizations, and agribusiness.

For more information, please visit www.blueandco.com.

Share this article

HRSA Officially Withdraws Current Rebate Model Pilot Program

HRSA Officially Withdraws Current 340B Rebate Model Pilot Program

After more than a month of uncertainty and legal challenges, HRSA formally revokes the 340B rebate model pilot program and pledges additional guidelines if a future pilot program is pursued. […]

Learn More
PAMA Clinical Lab Reporting Delayed Again: What Hospitals Should Know

PAMA Clinical Lab Reporting Delayed Again: What Hospitals Should Know

Congress has again postponed the next PAMA clinical lab reporting period. Hospitals and outreach labs should still prepare. The new guidelines moved the reporting window to May 1, 2026, through […]

Learn More
New Federal Requirements Will Reshape How Hospitals Manage Provider-Based Off Campus Outpatient Departments

New Federal Requirements Will Reshape How Hospitals Manage Provider-Based Off-Campus Outpatient Departments

A significant policy shift is about to reshape how hospitals structure, track, and bill for their off-campus Provider-Based Hospital Outpatient Departments (PB HOPDs). With the approval of Section 6225 of […]

Learn More